EW

Edwards Lifesciences Corporation

69.25 USD
+0.99 (+1.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Edwards Lifesciences Corporation stock is up 7.12% since 30 days ago. The next earnings date is Jan 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 23 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 50% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 Nov 14:59 17 Jan, 2025 55.00 CALL 51 13
27 Nov 14:48 17 May, 2024 67.50 CALL 78 147
27 Nov 15:03 17 Jan, 2025 75.00 CALL 59 74
29 Nov 15:15 17 Jan, 2025 35.00 CALL 50 64
29 Nov 19:44 19 Jan, 2024 85.00 PUT 19 787
04 Dec 16:45 19 Jan, 2024 62.50 PUT 553 2467
06 Dec 20:18 19 Jan, 2024 75.00 CALL 299 407
07 Dec 15:14 19 Jan, 2024 72.50 CALL 349 1040
08 Dec 14:47 17 May, 2024 62.50 CALL 38 79
08 Dec 20:33 21 Jun, 2024 70.00 PUT 58 262

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.

  • Morgan Stanley
    Mon Dec 4, 10:50
    buy
    confirm
  • Wolfe Research
    Tue Nov 28, 05:25
    sell
    downgrade